Table 5. SIDRO trial: differences in DDD per 1000 patients of prescribed drugs (intervention vs control).
prescribing outcomes(primary) | Absolute mean prescription duringfollow-up in the ‘intervention group’(DDD per 1000 patients) | Absolute difference at follow-up vscontrol group (change from baselineexpressed as DDD per 1000 patients) | m-ITT (95% CI)(1564 included GPs) |
prulifloxacin | 0.17 | −0.02 | −11.1% (−0.5 to −22,2%) |
barnidipine * | 1.94 | −0.21* | −9.8% (−1.9 to −18.2%) |
*a lower increase was observed in the intervention group.